SG Americas Securities
PRNB

SG Americas Securities’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

SG Americas Securities’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,871
Closed -$590K – 3802
2020
Q2 		$590K Sell
9,871
-986
-9% -$60.9K ﹤0.01% 1929
2020
Q1 		$645K Buy
10,857
+8,402
+342% +$490K 0.01% 1625
2019
Q4 		$134K Buy
+2,455
New +$91.7K ﹤0.01% 2775
2019
Q3 		– Sell
-6,349
Closed -$211K – 3343
2019
Q2 		$211K Buy
+6,349
New +$198K ﹤0.01% 2388

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

SG Americas Securities's PRNB Position: Q3 2020 in Review

SG Americas Securities sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 9,871 shares — an estimated $590K sold.

SG Americas Securities first reported a position in PRNB in Q2 2019 and held it in 4 quarters. The position peaked at $645K in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • SG Americas Securities reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 9,871 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $590K.
  • SG Americas Securities first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 4 quarters.
  • SG Americas Securities's Principia Biopharma Inc. Common Stock position peaked at $645K in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.